Hill Holler

Raw Political Coverage and Opinions

Home /
Lifeline Screening Partners With The Number One Medical Tech Manufacturer In Europe
;

Lifeline Screening Partners With The Number One Medical Tech Manufacturer In Europe

Osteoporosis is a major risk illness that affects people whose bone density decreases at a faster rate than it forms. Life Line Screening offers extensive screening services to help diagnose the condition before it advances to an adverse state. The physicians use ultrasound technology to detect abnormal thickness or density in bones. They critically analyze the tibia and give a conclusive result to the patient. Life Line screening advises candidates at the risk of developing osteoporosis to undergo a screening test at least once a year.

Statistics indicate that osteoporosis is a condition that affects millions of people across the world each year. The United States’ medical reports indicate that at least two million people suffer from broken bones every year. The medical resources and services used to attend to the patients total up to around $19 billion. Medical analysts estimate that the price will skyrocket to $25.3 billion in only eight years. The most expensive tool used in scanning bone density is the DXA X-Ray machine.

Life Line Screening has collaborated with Europe’s most prominent manufacturer of medical devices to heighten the efficiency of their services. Bone Index Limited is a top provider of medical technology and will be servicing Life Line Screening with innovative tools for various purposes. The firm’s Bindex point of care machine calculates the bone’s thickness while the embedded algorithm calculates the density index. Density at the hip is measured using the DXA tool.

The chief executive officer of Bone Index remarked that Life Line Screening would receive exponential services to help in all the screening events they host on an annual basis. Life Line Screening hosts approximately 15,000 events per year across the States. They test for indications of vascular abnormities and odd bone densities. The vice president of Life Line Screening seconded that remark by stating that Bone Index has privileged them with an opportunity to heighten the quality of their work and ultimately improve the lives of Americans. He is confident that Life Line Screening will be an exceptional firm in offering the best services in the industry.

The CEO of Bindex added that his company was enthusiastic to begin working with Life Line Screening. Bindex has 19 active patents in Europe, Japan, Chin and the United States. The firm has earned a name as a remarkable manufacture of medical tech and currently leads in osteoporosis screening in Finland. Life Line Screening revealed that they have an aim to foster a long-term relationship with the firm.

Learn More: en.wikipedia.org/wiki/Life_Line_Screening